Placeholder text
Cholesterol-Lowering Therapy
0 - Default Title
Description
covers tests of HMG CoA reductase inhibitors for patients with and without CHD
illuminates CHD risk factors such as diabetes, hypertension, obesity, and smoking
explores blood levels of homocysteine and lipoprotein(a) and other recently identified CHD risk factors
reviews metabolism of lipoproteins expressed in high (HDL) and low (LDL) density lipoprotein cholesterol
and more! Containing over 700 instructive tables, drawings, photographs, and bibliographic citations, Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence is a must-read resource for cardiologists, pharmacologists, and upper-level undergraduate, graduate, and medical school students in these disciplines.
Product details
Edition:
1
Number of Pages:
352
Release Date:
1999-11-05
Publication Date:
1999-11-05
Publisher:
CRC Press
Languages:
Original:
English
ISBN10:
082478216X08247835651842142690
ISBN13:
9780824782160
GPSR Manufacturer Reference:
Weight:
693 g
Height:
161 cm
Width:
240 cm
Thickness:
23 cm
Currently sold out